- A ‘Black Mirror’ spinoff mini-series is coming to YouTube via Netflix Latin America 2 Years Ago
- Kanye West appears on David Letterman’s Netflix show to talk Trump, TMZ, and Drake Today 3:27 PM
- QAnon believers link small-town arrest to deep state conspiracy without evidence Today 1:58 PM
- Instagram photos showing prison conditions spark massive protest Today 1:33 PM
- ‘Gay rat wedding’ headline sparks amazing new meme Today 1:03 PM
- ‘I read a gossip piece’ meme mocks Moby’s Instagram post Today 12:39 PM
- Rotten Tomatoes wants to see your ticket stub to leave a verified review Today 11:46 AM
- ‘Sonic the Hedgehog’ movie delayed to 2020 to fix his look Today 11:39 AM
- ‘Swamp Thing’ gets off to a promising start, but can it tell a convincing love story? Today 11:34 AM
- ‘Falling on deaf ears’: ‘Queer Eye’ star sparks conversation about ableist idioms Today 11:15 AM
- Parents are spending thousands on YouTube camps that teach kids how to be famous Today 10:43 AM
- In season 2 of ‘She’s Gotta Have It,’ Spike Lee remains unapologetically himself Today 10:36 AM
- Trump selling Pride shirts is a grotesque insult to the LGBTQ community Today 10:27 AM
- Logan Paul is being mocked for pulling out of slapping competition Today 9:57 AM
- 47 House Democrats sign criticized net neutrality working group letter Today 9:17 AM
Photo via JStone/Shutterstock (Licensed)
Shkreli faces up to 20 years in prison.
Martin Shkreli, the infamous “Pharma Bro,” has been found guilty of fraud.
After five days of deliberations, a federal jury in New York on Friday found Shkreli guilty on three of eight charges, two counts of securities fraud, and one count of conspiracy to commit securities fraud.
The conviction follows a five-week trial during which Shkreli boasted that he was “so innocent” and would receive an apology from prosecutors after the jury exonerated him.
Shkreli faces a maximum sentence of 20 years in prison.
The charges are related to Shkreli’s operation of a pair of hedge funds, MSMB Capital and MSMB Healthcare. After MSMB Capital collapsed in early 2011, Shkreli continued to send out statements to investors, pretending the fund was still making money despite the fact that it was entirely broke.
Shkreli then started a firm, Retrophin, which he used to pay back his MSMB investors.
In addition to Retrophin, Shkreli also led Turing Pharmaceutical. It was through Turing that Shkreli found his claim to infamy: Overnight, the company boosted the price of the drug Daraprim—which provides people with AIDS a lifesaving treatment for an infection called toxoplasmosis—from $13.50 to $750 per pill.
The Federal Bureau of Investigation arrested Shkreli in December 2015.
Shkreli embraced his villainous caricature. After the Daraprim debacle, he purchased the only copy of Wu-Tang’s million-dollar album, Once Upon a Time in Shaolin; gleefully harassed a Teen Vogue writer until he was kicked off Twitter; and played a track from Lil Wayne‘s unreleased 2014 album Tha Carter V.
Andrew Couts is the former editor of Layer 8, a section dedicated to the intersection of the Internet and the state—and the gaps in between. Prior to the Daily Dot, Couts served as features editor and features writer for Digital Trends, associate editor of TheWeek.com, and associate editor at Maxim magazine. When he’s not working, Couts can be found hiking with his German shepherds or blasting around on motorcycles.